A significant breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential malignant suppressor protein is frequently disabled in many forms of cancer, https://rotatesites.com/story23530498/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-hope-for-malignant-therapy